Argan
 Argan has released its 2025 results, a year the group described as "exceptional." During the period, rental income reached €212 million, up 7%.

Biosynex
Chembio Diagnostic Systems, a subsidiary of Biosynex, has announced a simultaneous review request for its DPP Syphilis test to the U.S. health authorities (FDA).

Covivio
The real estate group is accelerating its expansion in Southern Europe by acquiring a future MEININGER property from Eiffage Immobilier for €31.6 million, thereby strengthening its strategic partnership with the hotel operator.

GL Events
GL events posted 7.4% revenue growth in 2025 at constant exchange rates and 5.3% compared to the end of 2024, with record revenue of €1.721 billion.

Hoffmann Green Cement
The decarbonized cement specialist has received strategic financial support of €3 million to accelerate its Research and Development (R&D) programs, confirming its status as a high-potential company.

JCDecaux
 JC Decaux reports nearly 29 million rentals in 2025 for its self-service bicycles (VLS) in France, a 69% increase and a new all-time record. "By the end of December 2025, more than 233,400 long-term subscribers had been registered, a 21% increase compared to 2024, also marking a new performance milestone," added the outdoor communications group.

Kerlink
 Kerlink, a specialist in dedicated Internet of Things networks, posted 2025 revenue up 26%, at €14.7 million, despite what it described as a challenging economic environment.

Michelin
Michelin has finalized the acquisition of the Cooley group after obtaining all necessary approvals for the transaction. Cooley designs and manufactures innovative and sustainable polymer solutions for a wide range of applications, including medical devices, sealing, water and chemical retention, as well as other critical environmental solutions.

Sanofi
 Sanofi has released a set of data confirming the potential of its amlitelimab in moderate to severe atopic dermatitis. Based on these data, it will proceed with global regulatory submissions for this fully human monoclonal antibody.

Stef
The cold-chain logistics specialist achieved annual revenue of €5,119 million in 2025, up 6.6% on a reported basis (+4.7% like-for-like), reaching its strategic objectives earlier than expected, despite what it described as a "mixed" environment.

Transgene
 Transgene has announced the appointment of two new experts to its scientific committee. First is Professor Antoine Italiano, an internationally renowned medical oncologist specializing in early drug development and precision medicine. Next is Ignacio Melero, professor of immunology at the University of Navarra in Spain and co-director of the Department of Immunology and Immunotherapy at Clinica Universidad de Navarra.

Sword Group
 Sword Group reported EBITDA of €10.9 million for its fourth quarter of 2025, representing a margin of 12% on revenue of €90.8 million, up 12.2% at constant scope and exchange rates.

Voltalia
The energy company has reached a key milestone in its deleveraging by securing major new bank financing, aimed at supporting its self-financed growth trajectory.